| Authors: |
Yee DS; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Davies JP; Arbovirus Immunity Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., VanBlargan LA; Arbovirus Immunity Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Rahmberg AR; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Burgomaster KE; Arbovirus Immunity Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Brooks K; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Flynn JK; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Shue B; Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, NIAID, NIH, Hamilton, MT, USA., Ortiz AM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Schaughency P; Integrated Data Sciences Section, Research Technologies Branch, NIAID, NIH, Bethesda, MD, USA., Best SM; Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, NIAID, NIH, Hamilton, MT, USA., Pierson TC; Arbovirus Immunity Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA. |
